This Week’s Biotech Highlights
Everyone this week seemed to be extending a helping hand:
- The U.S. Senate reached out to small business, moving toward reauthorizing the popular SBIR grant program, even expanding eligibility to venture capital-funded companies this time around;
- Senator Kennedy, Governor Howard Dean and the National Venture Capital Association all reached out a hand to developers of novel biologic drugs, supporting at least 12 years of data exclusivity that would prevent the entry of biosimilars (an interesting development, since the adminstration has been pushing for only 7 years);
- The UK government is handing out “innovation passes” to developers of some novel
